このページの翻訳は実験的なもので、現在開発中です。フィードバックを お待ちしております!
MAYBAKER 株式概要 May & Baker Nigeria Plcは、その子会社とともに、ナイジェリアでヒト用医薬品、ヒト用ワクチン、消費者向け製品の製造、販売、流通を行っている。
May & Baker Nigeria plc 競合他社 価格と性能
の歴代最高値、変動、値下がりまとめMay & Baker Nigeria 過去の株価 現在の株価 ₦5.75 52週高値 ₦8.50 52週安値 ₦4.50 ベータ 0.0077 11ヶ月の変化 -14.18% 3ヶ月変化 5.12% 1年変化 5.50% 33年間の変化 42.33% 5年間の変化 140.59% IPOからの変化 329.34%
最新ニュース
Investor sentiment deteriorates as stock falls 16% Jun 12 May & Baker Nigeria plc, Annual General Meeting, Jun 06, 2024 May 15
Upcoming dividend of ₦0.30 per share May 15 May & Baker Nigeria plc, Annual General Meeting, Jun 06, 2024 May 14
Investor sentiment improves as stock rises 17% May 13
First quarter 2024 earnings released: EPS: ₦0.38 (vs ₦0.17 in 1Q 2023) May 01 最新情報をもっと見る
Investor sentiment deteriorates as stock falls 16% Jun 12 May & Baker Nigeria plc, Annual General Meeting, Jun 06, 2024 May 15
Upcoming dividend of ₦0.30 per share May 15 May & Baker Nigeria plc, Annual General Meeting, Jun 06, 2024 May 14
Investor sentiment improves as stock rises 17% May 13
First quarter 2024 earnings released: EPS: ₦0.38 (vs ₦0.17 in 1Q 2023) May 01
Investor sentiment improves as stock rises 19% Apr 04
Investor sentiment deteriorates as stock falls 18% Mar 06
Investor sentiment improves as stock rises 22% Feb 08
New minor risk - Share price stability Feb 04
Full year 2023 earnings released: EPS: ₦0.57 (vs ₦0.86 in FY 2022) Feb 01
Investor sentiment improves as stock rises 37% Jan 19
Third quarter 2023 earnings released: EPS: ₦0.016 (vs ₦0.54 in 3Q 2022) Nov 01
New major risk - Market cap size Oct 24
New minor risk - Share price stability Aug 09
Investor sentiment improves as stock rises 19% Aug 08
Second quarter 2023 earnings released: EPS: ₦0.23 (vs ₦0.17 in 2Q 2022) Jul 31
Investor sentiment improves as stock rises 16% Jul 14
Investor sentiment improves as stock rises 21% Jun 15
Upcoming dividend of ₦0.30 per share at 7.2% yield May 10
First quarter 2023 earnings released: EPS: ₦0.17 (vs ₦0.11 in 1Q 2022) Apr 29
Full year 2022 earnings released: EPS: ₦1.00 (vs ₦0.61 in FY 2021) Jan 31
No independent directors Nov 16
Third quarter 2022 earnings released: EPS: ₦0.54 (vs ₦0.19 in 3Q 2021) Oct 30
Investor sentiment improved over the past week Oct 04
Second quarter 2022 earnings released: EPS: ₦0.17 (vs ₦0.18 in 2Q 2021) Jul 31
First quarter 2022 earnings released: EPS: ₦0.11 (vs ₦0.14 in 1Q 2021) Apr 30
No independent directors Apr 27
Investor sentiment deteriorated over the past week Mar 10
Investor sentiment improved over the past week Feb 23
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Feb 02
Third quarter 2021 earnings released: EPS ₦0.19 (vs ₦0.14 in 3Q 2020) Oct 30
Second quarter 2021 earnings released: EPS ₦0.18 (vs ₦0.23 in 2Q 2020) Jul 27
Upcoming dividend of ₦0.50 per share May 12
First quarter 2021 earnings released: EPS ₦0.14 (vs ₦0.025 in 1Q 2020) May 03
Full year 2020 earnings released: EPS ₦0.56 (vs ₦0.41 in FY 2019) Mar 31
Investor sentiment deteriorated over the past week Feb 22
Investor sentiment improved over the past week Jan 28
New 90-day high: ₦4.01 Jan 25
Investor sentiment improved over the past week Jan 12
New 90-day high: ₦3.61 Dec 16
Market bids up stock over the past week Nov 12
New 90-day high: ₦3.45 Nov 09
Third quarter earnings released Nov 01
New 90-day high: ₦3.18 Oct 12
New 90-day low - ₦2.73 Aug 26
First half earnings released Aug 06 株主還元 MAYBAKER NG Pharmaceuticals NG 市場 7D 2.7% 8.8% 0.004% 1Y 5.5% 23.5% 95.3%
株主還元を見る
業界別リターン: MAYBAKER過去 1 年間で17.2 % の収益を上げたNG Pharmaceuticals業界を下回りました。
リターン対市場: MAYBAKERは、過去 1 年間で96.6 % のリターンを上げたNG市場を下回りました。
価格変動 Is MAYBAKER's price volatile compared to industry and market? MAYBAKER volatility MAYBAKER Average Weekly Movement 7.8% Pharmaceuticals Industry Average Movement 4.0% Market Average Movement 6.9% 10% most volatile stocks in NG Market 10.3% 10% least volatile stocks in NG Market 0.8%
安定した株価: MAYBAKER過去 3 か月間に大きな価格変動はありませんでした。
時間の経過による変動: MAYBAKERの 週次ボラティリティ ( 8% ) は過去 1 年間安定しています。
会社概要 May & Baker Nigeria Plcは、子会社とともにナイジェリアでヒト用医薬品、ヒト用ワクチン、消費者向け製品の製造、販売、流通を行っている。医薬品部門と飲料部門を通じて事業を展開している。同社は、抗糖尿病薬、抗ヒスタミン薬、抗感染症薬、抗マラリア薬、鎮痛薬、咳止め薬、風邪薬、抗不安薬などの医薬品と、ネイチャーケア製品を提供している。また、「リリーウォーター」の名称でボトル入り飲料水を含む飲料水、「スマータンス」の名称で手指・表面消毒剤も提供している。さらに、医薬品の受託製造、ヘルスケアおよび工業用パッケージングにも取り組んでいる。メイ&ベーカー・ナイジェリアPlcは1944年に設立され、ナイジェリアのラゴスに本社を置いている。
もっと見る May & Baker Nigeria plc 基礎のまとめ May & Baker Nigeria の収益と売上を時価総額と比較するとどうか。 MAYBAKER 基礎統計学 時価総額 ₦9.92b 収益(TTM) ₦1.45b 売上高(TTM ) ₦21.87b
収益と収入 最新の決算報告書(TTM)に基づく主な収益性統計 MAYBAKER 損益計算書(TTM) 収益 ₦21.87b 売上原価 ₦14.25b 売上総利益 ₦7.62b その他の費用 ₦6.16b 収益 ₦1.45b
一株当たり利益(EPS) 0.84 グロス・マージン 34.83% 純利益率 6.65% 有利子負債/自己資本比率 66.9%
MAYBAKER の長期的なパフォーマンスは?
過去の実績と比較を見る Simply Wall St™ Simply Wall Street Pty Ltd Level 7, 320 Pitt Street, Sydney Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.